Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Ultralife Corporation Reports First Quarter Results

May 2, 2019

NEWARK, N.Y., May 02, 2019 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.5 million on revenue of $18.9 million for the first quarter ended March 31, 2019 compared to operating income of $2.4 million on revenue of $23.1 million for the first quarter ended April 1, 2018.

First Quarter 2019 Financial Results

“First quarter results were significantly impacted by a reduction in government/defense sales largely due to delays of amplifier shipments under the U.S. Army’s Network Modernization initiatives by Communications Systems. We are now operating at a higher rate of amplifier production and have produced more units in the month of April than during the entire first quarter. In addition, normal fluctuations in government/defense order flow resulted in a decline in Battery & Energy Products sales that was buffered by continued strength in medical sales,” said Michael D. Popielec, President and Chief Executive Officer. “With key amplifier product shipments now increasing and robust opportunities for growth from our diversified set of commercial and government/defense customers ahead of us, we remain well positioned for another year of profitable growth in 2019.”

Revenue was $18.9 million, a decrease of $4.2 million, or 18.2%, compared to $23.1 million for the first quarter of 2018. Battery & Energy Products sales decreased $1.2 million, or 7.1%, to $16.0 million compared to $17.2 million last year due primarily to timing differences in government/defense shipments, not fully offset by a 10.4% increase in medical sales. Communications Systems sales decreased 50.7% to $2.9 million compared to $5.8 million for the same period last year as the initial start-up production and shipment of products to support the U.S. Army’s Network Modernization initiatives under the delivery orders announced in October 2018 were less than Q1 2018 shipments of Vehicle Amplifier Adapters for the U.S. Army’s Special Force Assistance Brigades under a contract awarded in December 2017 and shipments of power supplies to a large global defense prime contractor.

Gross profit was $5.1 million, or 26.9% of revenue, compared to $7.3 million, or 31.6% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin was 27.6%, compared to 29.2% last year, primarily due to sales mix. Communications Systems’ gross margin was 23.4%, compared to 38.4% last year, primarily due to costs incurred to commence production of Communications Systems large program awards received in October 2018 for shipment in 2019.

Operating expenses were $4.5 million compared to $4.9 million last year reflecting continued tight control over discretionary spending. Operating expenses were 24.0% of revenue compared to 21.4% of revenue for the year-earlier period.

Operating income was $0.5 million compared to $2.4 million last year for an operating margin of 2.9% compared to 10.2% last year.

Net income was $0.4 million, or $0.03 per share, compared to net income of $2.2 million, or $0.14 per share ($0.13 per diluted share), for the first quarter of 2018.

Acquisition of Southwest Electronic Energy Corporation

Ultralife also announced today that it has acquired all of the outstanding shares of Southwest Electronic Energy Corporation (“SWE”), including its ISO certified manufacturing and technology facility, for $25.0 million in cash, subject to a customary working capital adjustment.

Based in Missouri City, TX, SWE is a leading independent designer and manufacturer of high-performance smart battery systems and battery packs to customer specifications using Lithium cells. SWE serves a variety of industrial markets, including oil & gas, remote monitoring, process control and marine, which demand uncompromised safety, service, reliability and quality.

For the trailing twelve-month period ended December 31, 2018, SWE generated revenue of over $28 million. The transaction is expected to be accretive on an EPS basis within 12 months.

“This acquisition advances our strategy of commercial revenue diversification and enhances the operating leverage of our business model. SWE checks nearly every box in our profile of an ideal acquisition candidate: a complementary line of highly engineered, mission critical, differentiated products; a blue-chip customer base; an innovative culture similar to our own; an experienced technical engineering and new product development team; a very strong management team; and a business model aligned with our core business. We welcome the SWE team to Ultralife and look forward to a smooth integration process,” said Michael D. Popielec, President and Chief Executive Officer.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company’s business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

Conference Call Information

Ultralife will hold a conference call today at 8:30 AM ET to discuss first quarter results and the acquisition. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: potential reductions in revenues from key customers, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company’s analysis only as of today’s date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

ULTRALIFE CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Dollars in Thousands) (Unaudited) ASSETS December 31, March 31, 2018 2019 As Adjusted (1) --------- ------------ Current Assets: Cash $21,240 $25,934 Trade Accounts Receivable, Net 13,938 16,015 Inventories, Net 27,906 22,843 Prepaid Expenses and Other Current Assets 2,397 2,368 --------- ------------ Total Current Assets 65,481 67,160 Property, Equipment and Improvements, Net 12,398 10,744 Goodwill 20,251 20,109 Other Intangible Assets, Net 6,484 6,504 Deferred Income Taxes, Net 15,421 15,444 Other Noncurrent Assets 916 887 --------- ------------ Total Assets $120,951 $120,848 --------- ------------ LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Accounts Payable $11,307 $9,919 Accrued Compensation and Related Benefits 1,364 1,494 Accrued Expenses and Other Current Liabilities 3,325 3,973 --------- ------------ Total Current Liabilities 15,996 15,386 Deferred Income Taxes 564 591 Other Noncurrent Liabilities 468 408 --------- ------------ Total Liabilities 17,028 16,385 Shareholders’ Equity: Common Stock 2,013 2,005 Capital in Excess of Par Value 183,163 182,630 Accumulated Deficit (57,610) (58,035) Accumulated Other Comprehensive Loss (2,351) (2,786) Treasury Stock (21,231) (19,266) --------- ------------ Total Ultralife Equity 103,984 104,548 Non-Controlling Interest (61) (85) --------- ------------ Total Shareholders’ Equity 103,923 104,463 --------- ------------ Total Liabilities and Shareholders’ Equity $120,951 $120,848 --------- ------------

1. Effective January 1, 2019, the Company adopted Accounting Standards Codification Topic 842 (ASC 842), Leases. Pursuant to ASC 842, lease liabilities and right-of-use assets for the Company’s operating leases have been recognized on the consolidated balance sheet. Lease liabilities are recorded as other current and other noncurrent liabilities. Right-of-use assets are recorded as other noncurrent assets. For comparability, the Company has elected to recast the prior year comparative period to recognize the effects of ASC 842 including the recognition to equity of a $71 cumulative effect adjustment.

ULTRALIFE CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME (In Thousands Except Per Share Amounts) (Unaudited) ------------------- Three-Month Periods Ended ------------------- March 31, April 1, 2019 2018 --------- -------- Revenues: Battery & Energy Products $15,998 $17,224 Communications Systems 2,884 5,845 --------- -------- Total Revenues 18,882 23,069 --------- -------- Cost of Products Sold: Battery & Energy Products 11,588 12,188 Communications Systems 2,210 3,599 --------- -------- Total Cost of Products Sold 13,798 15,787 --------- -------- Gross Profit 5,084 7,282 --------- -------- Operating Expenses: Research and Development 1,036 1,101 Selling, General and Administrative 3,500 3,825 --------- -------- Total Operating Expenses 4,536 4,926 --------- -------- Operating Income 548 2,356 Other Expense (58) (133) --------- -------- Income Before Income Tax Provision 490 2,223 Income Tax Provision (41) (55) --------- -------- Net Income 449 2,168 Net Income Attributable to Non-Controlling Interest (24) (17) --------- -------- Net Income Attributable to Ultralife Corporation $425 $2,151 --------- -------- Net Income Per Share Attributable to Ultralife Common Shareholders – Basic $0.03 $0.14 Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted $0.03 $0.13 Weighted Average Shares Outstanding – Basic 15,740 15,704 Weighted Average Shares Outstanding – Diluted 16,225 16,202

Company Contact: Ultralife Corporation Philip A. Fain (315) 210-6110 pfain@ulbi.com

Investor Relations Contact:LHA Jody Burfening(212) 838-3777 jburfening@lhai.com